A Study to Examine MPI SPECT Imaging With BMS068645 and Adenosine Compared to Coronary Angiography

Forest Laboratories

Status and phase: Terminated; Phase 3

Conditions: Ischemic Heart Disease; Heart Disease

Treatments: Drug: apadenoson

Study type: Interventional

Funder types: Industry

Identifiers

NCT00162084

BMS068645-302

Details and patient eligibility

About

The purpose of the study is to determine whether BMS068645 is as effective as Adenosine SPECT at detecting blockages in heart arteries, and to determine if it will have fewer side effects

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Referral for pharmacologic stress SPECT MPI
• Have suspected Ischemic heart disease

Exclusion criteria

• Acute myocardial Infarction, Coronary artery bypass graft, percutaneous coronary intervention within 30 days of enrollment
• Severe asthma or COPD

Trial design

Primary purpose: Diagnostic

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind